KR20100017510A - 약물 용출 스텐트로 처치된 개체의 혈소판 반응성을 측정하는 방법 - Google Patents

약물 용출 스텐트로 처치된 개체의 혈소판 반응성을 측정하는 방법 Download PDF

Info

Publication number
KR20100017510A
KR20100017510A KR1020097024975A KR20097024975A KR20100017510A KR 20100017510 A KR20100017510 A KR 20100017510A KR 1020097024975 A KR1020097024975 A KR 1020097024975A KR 20097024975 A KR20097024975 A KR 20097024975A KR 20100017510 A KR20100017510 A KR 20100017510A
Authority
KR
South Korea
Prior art keywords
platelet
particles
aggregation
adp
gpiib
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097024975A
Other languages
English (en)
Korean (ko)
Inventor
배리 에스. 콜러
데니스 더빈
Original Assignee
아큐메트릭스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아큐메트릭스, 인크. filed Critical 아큐메트릭스, 인크.
Publication of KR20100017510A publication Critical patent/KR20100017510A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/222—Platelet disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020097024975A 2007-05-01 2008-05-01 약물 용출 스텐트로 처치된 개체의 혈소판 반응성을 측정하는 방법 Ceased KR20100017510A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/742,684 2007-05-01
US11/742,684 US20070243632A1 (en) 2003-07-08 2007-05-01 Methods for measuring platelet reactivity of patients that have received drug eluting stents

Publications (1)

Publication Number Publication Date
KR20100017510A true KR20100017510A (ko) 2010-02-16

Family

ID=39615637

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097024975A Ceased KR20100017510A (ko) 2007-05-01 2008-05-01 약물 용출 스텐트로 처치된 개체의 혈소판 반응성을 측정하는 방법

Country Status (6)

Country Link
US (2) US20070243632A1 (enExample)
EP (1) EP2145192A1 (enExample)
JP (1) JP5687055B2 (enExample)
KR (1) KR20100017510A (enExample)
CN (1) CN101688871A (enExample)
WO (1) WO2008137600A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536889T1 (de) * 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7595169B2 (en) * 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
US20080299587A1 (en) * 2007-05-03 2008-12-04 Dennis Durbin Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
EP2371284A1 (en) * 2010-03-24 2011-10-05 C A Casyso AG Method and apparatus for determining at least one evaluation parameter of a blood sample
RU2442167C1 (ru) * 2010-07-21 2012-02-10 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ оценки эффективности действия антиагрегантных препаратов, влияющих на метаболизм арахидоновой кислоты путем ингибирования циклооксигеназы-1 как в отдельности, так и совместно с антагонистом рецептора адф p2y12 на тромбоцитарных мембранах, на состояния тромбоцитов крови пациента, принимающего антиагрегантные препараты указанной группы
JP5768422B2 (ja) * 2011-03-17 2015-08-26 ソニー株式会社 血液凝固系解析方法および血液凝固系解析装置
EP2508892A1 (de) 2011-04-04 2012-10-10 Siemens Healthcare Diagnostics Products GmbH Kontrollen und Kit für Thrombozytenaktivitätsteste
DE102014112270B3 (de) * 2014-08-27 2015-04-23 Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V. Verfahren zur Messung der Thrombozytenfunktion
US10539579B2 (en) 2014-09-29 2020-01-21 C A Casyso Gmbh Blood testing system and method
GB201503425D0 (en) * 2015-02-27 2015-04-15 Randox Lab Ltd Prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention
MX2017012732A (es) * 2015-04-08 2017-11-30 Koninklijke Philips Nv Sistema para analisis automatizado de valores de laboratorio y notificacion de riesgo en unidad de cuidados intensivos.
CN105203752A (zh) * 2015-11-05 2015-12-30 上海中山医疗科技发展公司 一种磁性血小板吸附颗粒及其制备方法
CN105717263B (zh) * 2016-03-04 2018-01-26 北京乐普医疗科技有限责任公司 一种检测噻吩并吡啶类抗血小板药物疗效的试剂卡及其使用方法和应用
AU2022205600A1 (en) * 2021-01-07 2023-07-06 Baxter Healthcare Sa Thrombin-free hemostatic materials, methods of manufacture, and uses thereof
WO2023238136A1 (en) * 2022-06-08 2023-12-14 Ichilov Tech Ltd. Methods of assessing platelet aggregation

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US409758A (en) * 1889-08-27 Velocipede
US3518057A (en) * 1966-04-22 1970-06-30 Huron Road Hospital Method and apparatus for thrombus formation time determinations
US3694161A (en) * 1971-04-14 1972-09-26 Armour Pharma Method for measuring platelet aggregation
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4051236A (en) * 1973-02-15 1977-09-27 E. R. Squibb & Sons, Inc. Inhibition of blood platelet aggregation
FI58700C (fi) * 1974-02-21 1981-03-10 Braun Melsungen Ag Foerfarande foer maetning av blodplaettars spontanaaggregation i blodplaettsrik citratplasma
US4529561A (en) 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
JPS5697226A (en) 1979-12-28 1981-08-05 Mitsubishi Chem Ind Ltd Blood platelet coagulation inhibitor
US4622293A (en) 1983-07-05 1986-11-11 Miles Laboratories, Inc. Iodothyronine immunoassays employing HMS as TBP blocking agent
US4717654A (en) 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay
US4619904A (en) 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4634681A (en) 1984-10-29 1987-01-06 General Electric Company Diagnostic method of determining the presence or absence of select proteins in a liquid sample
US4948961A (en) 1985-08-05 1990-08-14 Biotrack, Inc. Capillary flow device
CA1284642C (en) * 1986-03-31 1991-06-04 Hikozo Iwakura Prostacyclin (pgi ) analogues
DE3717337A1 (de) * 1987-05-22 1988-12-15 Hoechst Ag Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern
US5114842A (en) 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5066592A (en) * 1988-03-08 1991-11-19 Temple University Of The Commonwealth System Of Higher Education Trigramin - a platelet aggregation inhibiting polypeptide
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
BR9106391A (pt) 1990-04-30 1993-04-27 Isis Pharmaceuticals Inc Oligonucleotideo ou analogo de oligonucleotideo,processo para modular o metaboslismo do acido araquidonico em um animal,e,processo para tratar um anumal suspeito de ter uma doenca que e modulada por mudancas na sintese ou no metabolismo do acido arquidonico
US5246832A (en) 1990-06-20 1993-09-21 University Of Massachusetts Medical Center Platelet analysis in whole blood
US5196309A (en) 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5266462A (en) 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
US5427913A (en) 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
AU7112794A (en) 1993-06-18 1995-01-17 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5455228A (en) * 1993-07-02 1995-10-03 The Research Foundation Of State University Of New York Peptidase resistant thrombin receptor peptide ligand
IL106330A (en) 1993-07-14 1998-01-04 Univ Ramot Method and instrument for determining the activity of their plaques in the initial coagulation system
US5486361A (en) 1993-10-25 1996-01-23 The United States Of America As Represented By The Department Of Health And Human Services Hybridomas and monoclonal antibodies that speifically bind to GPIB on platelets and inhibit the binding of thrombin to platelets
DE4344919A1 (de) 1993-12-30 1995-07-06 Behringwerke Ag Verfahren zur Bestimmung der Thrombozytenaggregation
WO1995027209A1 (en) 1994-03-31 1995-10-12 The Trustees Of The University Of Pennsylvania Method and kit for detection of thrombin receptor activation of platelets and other cells
ATE186121T1 (de) 1994-07-23 1999-11-15 Roche Diagnostics Gmbh Verfahren zur bestimmung des präthrombotischen status
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
US5952006A (en) 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
FR2744918B1 (fr) * 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
US5753517A (en) 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US6221672B1 (en) * 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
US6043871A (en) * 1997-03-03 2000-03-28 Brigham Young University System and method for measuring blood platelet function
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6010911A (en) 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6016712A (en) * 1997-09-18 2000-01-25 Accumetrics Device for receiving and processing a sample
US6210904B1 (en) * 1997-10-14 2001-04-03 Merck & Co., Inc. Anticoagulant test
DE69825173T2 (de) 1997-10-30 2005-08-25 Morishita Jintan Co. Ltd. Doppelschichtige kapsel von ungesättigten fettsäuren oder deren derivate und verfahren zu deren herstellung
US6063847A (en) * 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
USD409758S (en) * 1998-01-14 1999-05-11 Accumetrics Sample cartridge
JP2002504369A (ja) 1998-02-27 2002-02-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プロテアーゼ活性化レセプター４およびその使用。
EP0964046B1 (en) 1998-06-03 2003-07-30 Mitsubishi Gas Chemical Company, Inc. Oxygen absorbing composition, oxygen absorbing resin and preserving method
US6093370A (en) 1998-06-11 2000-07-25 Hitachi, Ltd. Polynucleotide separation method and apparatus therefor
US6387645B1 (en) * 1998-07-16 2002-05-14 Hyseq, Inc. Methods and materials relating to novel CD39-like polypeptides
CN1189166C (zh) 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
WO2000025140A1 (en) 1998-10-23 2000-05-04 Accumetrics, Inc. Method for determining platelet count
WO2000073792A1 (en) 1999-05-28 2000-12-07 Sendx Medical, Inc. Control for methods for determining platelet count and platelet function
EP1216037A2 (en) * 1999-09-21 2002-06-26 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
US6994983B2 (en) * 1999-10-25 2006-02-07 Esoterix, Inc. Coagulation Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage
US6589992B2 (en) 1999-11-30 2003-07-08 Parker Hughes Institute Inhibiting collagen-induced platelet aggregation
AU5959201A (en) 2000-05-11 2001-11-20 Bristol Myers Squibb Co Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
US6645987B2 (en) * 2000-06-15 2003-11-11 Schering Corporation Nor-seco himbacine derivatives useful as thrombin receptor antagonists
US20020077693A1 (en) * 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
WO2002026109A2 (en) 2000-09-29 2002-04-04 Endovasc Ltd., Inc. Resorbable prosthesis for medical treatment
AU2002210982A1 (en) 2000-11-01 2002-05-15 Yamanouchi Pharmaceutical Co..Ltd. Method of screening antiplatelet
US6841354B2 (en) 2000-12-21 2005-01-11 Philadelphia, Health & Education Corporation Screening assay for anti-thrombotic/anti-platelet activity
CN1243735C (zh) * 2001-04-19 2006-03-01 卫材株式会社 2－亚氨基吡咯烷衍生物
CA2450236A1 (en) 2001-07-06 2003-01-16 Genentech, Inc. Phage displayed pdz domain ligands
JP4307260B2 (ja) * 2001-10-18 2009-08-05 シェーリング コーポレイション トロンビンレセプタアンタゴニストとしてのヒンバシン類似物
US6833536B2 (en) 2002-05-22 2004-12-21 Applera Corporation Non-contact radiant heating and temperature sensing device for a chemical reaction chamber
FR2840409B1 (fr) * 2002-05-28 2004-08-27 Dev Des Antigenes Combinatoire Dispositif de presentation de peptides ou de proteines, son procede de preparation et ses utilisations
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
AU2003277398A1 (en) 2002-10-15 2004-05-04 The University Of Tennessee Research Foundation Methods for assessment of platelet aggregation
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ATE536889T1 (de) 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US7595169B2 (en) * 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
US7205115B2 (en) * 2005-04-28 2007-04-17 Accumetrics, Inc. Method and system for stabilization of arachidonic acid for use in platelet function assay
WO2007007588A1 (ja) 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. 平面性を有する環状基を母核とする化合物
US20080299587A1 (en) * 2007-05-03 2008-12-04 Dennis Durbin Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
CA2697635C (en) 2007-11-30 2016-06-28 Corbett Research Pty Ltd Thermal cycling device

Also Published As

Publication number Publication date
US20100184084A1 (en) 2010-07-22
JP5687055B2 (ja) 2015-03-18
US9506938B2 (en) 2016-11-29
WO2008137600A1 (en) 2008-11-13
JP2010526300A (ja) 2010-07-29
US20070243632A1 (en) 2007-10-18
EP2145192A1 (en) 2010-01-20
CN101688871A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
KR20100017510A (ko) 약물 용출 스텐트로 처치된 개체의 혈소판 반응성을 측정하는 방법
US8574828B2 (en) Controlled platelet activation to monitor therapy of ADP antagonists
Zanetto et al. Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death
JP5514101B2 (ja) トロンビンレセプターアンタゴニストによる血小板凝集阻害を測定する方法
US9789166B2 (en) Assessment of cardiac health and thrombotic risk in a patient
Collyer et al. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography® Platelet Mapping™
Wiinberg et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation
Gurbel et al. Delayed thrombin-induced platelet–fibrin clot generation by clopidogrel: A new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting
Gibbs Point-of-care assessment of antiplatelet agents in the perioperative period: a review
Mason et al. The current role of platelet function testing in clinical practice
US20170292965A1 (en) Detection of restensosis risk in patients receiving a stent
Yaoi et al. Role of red blood cells in the anemia‐associated bleeding under high shear conditions
Peerschke The laboratory evaluation of platelet dysfunction
Van Werkum et al. Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence
HK1142680A (en) Methods for measuring platelet reactivity of individuals treated with drug eluting stents
Disharoon et al. PlateChek: a surface-functionalized dielectric microsensor for specific detection of platelet-related hemostatic impairment in whole blood
WO2002059623A2 (en) Methods for determining platelet activity with antiplatelet compositions
JP5989893B2 (ja) インテグリンβサブユニットの静脈血栓塞栓の診断における使用
Douglas Genetic influences on platelet function in coronary artery disease and myocardial infarction
Hobson A Novel method of Thrombelastograph analysis aids assessment of antiplatelet therapy in percutaneous coronary intervention.

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20091130

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130430

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141014

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150430

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141014

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I